FDA 药品与器械查询
实时对接美国 FDA 官方开放数据(openFDA),可查询美国上市药品 NDC 目录、医疗器械管理类别与 21 CFR 法规号、以及已获许可的 510(k) 清单,用于出海美国的准入判断、注册路径选择与同类竞品调研。支持中文关键词自动转英文检索。
数据源:美国 FDA 官方开放数据平台 openFDA,实时查询美国上市药品 NDC 目录、器械分类与 510(k) 许可,用于出海美国的准入与合规自查。
支持中文关键词自动转英文检索;此为美国监管口径,与中国 NMPA 批准情况相互独立。
查询美国市场在售药品:剂型、给药途径、活性成分、持证商与 NDC 编码,用于判断目标品种在美国是否已有同类上市。
已将中文关键词转为英文「insulin」检索 FDA 数据库。
共找到 220 条与「insulin」匹配的结果
当前展示 50 条美国 FDA 上市药品记录; 海关数据库提供全球买卖明细与竞争对手出货记录咨询完整数据 ›
| 药品名称 | NDC 编码 | 剂型 | 给药途径 | 活性成分 | 持证商 | 上市类别 |
|---|---|---|---|---|---|---|
Humalog Mix75/25 Insulin lispro | 0002-7511 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN LISPRO 100 [iU]/mL | Eli Lilly and Company | BLA |
Insulin Degludec insulin degludec | 73070-403 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN DEGLUDEC 100 U/mL | Novo Nordisk Pharma, Inc. | BLA |
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 insulin aspart | 73070-200 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk Pharma, Inc. | BLA |
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 insulin aspart | 73070-203 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk Pharma, Inc. | BLA |
Apidra SoloStar insulin glulisine | 0088-2502 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLULISINE 100 [iU]/mL | sanofi-aventis U.S. LLC | BLA |
Insulin Degludec insulin degludec | 73070-400 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN DEGLUDEC 100 U/mL | Novo Nordisk Pharma, Inc. | BLA |
Insulin Lispro KwikPen Insulin lispro | 0002-8222 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN LISPRO 100 [iU]/mL | Eli Lilly and Company | BLA |
Insulin Degludec insulin degludec | 50090-7176 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN DEGLUDEC 100 U/mL | A-S Medication Solutions | BLA |
INSULIN DILUTING MEDIUM FOR Kirsty water | 83257-006 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | WATER 1 mL/mL | Biocon Biologics Inc. | BLA |
KIRSTY insulin aspart-xjhz | 83257-007 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Biocon Biologics Inc. | BLA |
Insulin Diluting Medium for NovoLog water injection | 0169-2001 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | WATER 1 mL/mL | Novo Nordisk | BLA |
Fiasp insulin aspart injection | 0169-3205 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk | BLA |
KIRSTY insulin aspart-xjhz | 83257-008 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Biocon Biologics Inc. | BLA |
Insulin lispro Insulin lispro | 62381-9516 | INJECTION, SOLUTION | — | INSULIN LISPRO 100 [iU]/mL | Lilly France | DRUG FOR FURTHER PROCESSING |
Insulin Degludec insulin degludec | 50090-7175 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN DEGLUDEC 200 U/mL | A-S Medication Solutions | BLA |
Tresiba insulin degludec | 50090-3491 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN DEGLUDEC 200 U/mL | A-S Medication Solutions | BLA |
SEMGLEE insulin glargine-yfgn | 83257-011 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | Biocon Biologics Inc. | BLA |
SEMGLEE insulin glargine-yfgn | 83257-012 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | Biocon Biologics Inc. | BLA |
Insulin Glargine insulin Glargine-yfgn | 83257-014 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | Biocon Biologics Inc. | BLA |
LYUMJEV Tempo Pen Insulin lispro-aabc | 0002-8235 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN LISPRO 100 [iU]/mL | Eli Lilly and Company | BLA |
Lantus Solostar insulin glargine | 0088-2219 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | sanofi-aventis U.S. LLC | BLA |
TOUJEO insulin glargine | 50090-2193 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 300 U/mL | A-S Medication Solutions | BLA |
Insulin Glargine insulin Glargine-yfgn | 83257-015 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | Biocon Biologics Inc. | BLA |
Fiasp insulin aspart | 0169-3206 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk | BLA |
Humalog Mix50/50 KwikPen Insulin lispro | 0002-8798 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN LISPRO 100 [iU]/mL | Eli Lilly and Company | BLA |
NOVOLOG insulin aspart | 0169-3303 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk | BLA |
Lantus insulin glargine | 0088-2220 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | sanofi-aventis U.S. LLC | BLA |
Humulin N Insulin human | 0002-8805 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN HUMAN 100 [iU]/mL | Eli Lilly and Company | BLA |
Apidra insulin glulisine | 0088-2500 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN GLULISINE 100 [iU]/mL | sanofi-aventis U.S. LLC | BLA |
Recombinant Human Insulin Recombinant Human Insulin | 69098-101 | POWDER | — | INSULIN HUMAN 1 g/g | Amphastar France Pharmaceuticals | BULK INGREDIENT |
NovoLog Mix 70/30 insulin aspart | 50090-2272 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | A-S Medication Solutions | BLA |
Recombinant Human Insulin Recombinant Human Insulin | 69098-101 | POWDER | — | INSULIN HUMAN 1 g/g | Amphastar France Pharmaceuticals, Inc. | BULK INGREDIENT |
NovoLog Mix 70/30 insulin aspart | 0169-3685 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk Pharmaceutical Industries, LP | BLA |
Insulin Aspart insulin aspart | 73070-103 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk Pharma, Inc. | BLA |
Insulin Aspart insulin aspart | 73070-100 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk Pharma, Inc. | BLA |
Insulin Aspart insulin aspart | 73070-102 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk Pharma, Inc. | BLA |
NOVOLOG insulin aspart | 0169-6339 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk | BLA |
Insulin Aspart insulin aspart | 50090-4956 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | A-S Medication Solutions | BLA |
Garzulys insulin aspart-fsan | 71288-904 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Meitheal Pharmaceuticals Inc. | BLA |
Insulin Aspart insulin aspart | 50090-4955 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | A-S Medication Solutions | BLA |
Garzulys insulin aspart-fsan | 71288-903 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Meitheal Pharmaceuticals Inc. | BLA |
BASAGLAR KwikPen Insulin glargine | 0002-7715 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | Eli Lilly and Company | BLA |
.Insulin Aspart Protamine and Insulin Aspart insulin aspart | 50090-4959 | INJECTION, SUSPENSION | SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | A-S Medication Solutions | BLA |
Insulin Diluting Medium for Garzulys water injection | 71288-909 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | WATER 1 mL/mL | Meitheal Pharmaceuticals Inc. | BLA |
Levemir insulin detemir | 50090-1276 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN DETEMIR 100 [iU]/mL | A-S Medication Solutions | BLA |
TOUJEO insulin glargine | 0024-5869 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 300 U/mL | Sanofi-Aventis U.S. LLC | BLA |
Rezvoglar KwikPen Insulin glargine-aglr | 0002-8980 | INJECTION, SOLUTION | SUBCUTANEOUS | INSULIN GLARGINE 100 [iU]/mL | Eli Lilly and Company | BLA |
Insulin Lispro Insulin lispro | 0002-7737 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN LISPRO 100 [iU]/mL | Eli Lilly and Company | BLA |
HUMALOG Insulin lispro | 50090-1375 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN LISPRO 100 [iU]/mL | A-S Medication Solutions | BLA |
NOVOLOG insulin aspart | 0169-2100 | INJECTION, SOLUTION | INTRAVENOUS、SUBCUTANEOUS | INSULIN ASPART 100 [iU]/mL | Novo Nordisk | BLA |
数据随 FDA 官方库更新,仅供参考,不构成医学或法律建议;正式注册与报关请以 FDA 官方文件及最新法规为准。
